Cumberland Pharmaceuticals Inc. (CPIX) vs Cardiol Therapeutics Inc. (CRDL)

Cumberland Pharmaceuticals Inc. and Cardiol Therapeutics Inc. are both Drug Manufacturers Specialty & Generic companies. Cardiol Therapeutics Inc. is the larger, with a market value of $202.1M against $120.0M — 1.7× the size. Cardiol Therapeutics Inc. has the higher net margin (0.00% vs −26.2%) and the higher return on invested capital (0.00% vs −34.2%). Across the 14 metrics below, Cumberland Pharmaceuticals Inc. leads on 10 and Cardiol Therapeutics Inc. on 4.

Valuation

Metric CPIX CRDL Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 2.73 n/m 2.25
P/B 6.66 11.32 1.90
Price to free cash flow 197.97 n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 2.89 n/m 2.56
Earnings yield (9.33%) (14.62%) (2.99%)
Free cash flow yield 0.51% (8.77%) 0.00%

Profitability

Metric CPIX CRDL Drug Manufacturers Specialty & Generic median
Gross margin 82.80% 0.00% 53.94%
Operating margin (17.39%) 0.00% 0.00%
Net margin (26.17%) 0.00% 0.00%
Free cash flow margin 1.38% 0.00% 0.00%
Return on equity (48.76%) (171.13%) (0.40%)
Return on assets (16.70%) (124.40%) (3.32%)
Return on invested capital (34.23%) 0.00% 0.00%

Growth

Metric CPIX CRDL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 31.98% — 10.01%
EPS growth (last fiscal year) 58.70% 24.32% —
Revenue growth, 5-year CAGR 3.52% — 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CPIX CRDL Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 0.96 5.55 2.31
Net debt to EBITDA (4.58) 0.62 0.85

Dividend

Metric CPIX CRDL Drug Manufacturers Specialty & Generic median
Dividend yield 2.07% — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric CPIX CRDL Drug Manufacturers Specialty & Generic median
Market cap 120.01m 202.10m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack